Epigenetic Regulation of Hepatic Lipid Metabolism by DNA Methylation
Advanced Science · 2023-07 · 10 (20)
DOI: 10.1002/advs.202206068 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 06.06.2023. Verfasst von Shirong Wang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Georgia State University, Atlanta, GA, 30303, USA. Hauptthemen laut MEDLINE: Lipid Metabolism, Fatty Liver. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
While extensive investigations have been devoted to the study of genetic pathways related to fatty liver diseases, much less is known about epigenetic mechanisms underlying these disorders. DNA methylation is an epigenetic link between environmental factors (e.g., diets) and complex diseases (e.g., non‐alcoholic fatty liver disease). Here, it is aimed to study the role of DNA methylation in the regulation of hepatic lipid metabolism. A dynamic change in the DNA methylome in the liver of high‐fat diet (HFD)‐fed mice is discovered, including a marked increase in DNA methylation at the promoter of Beta‐klotho ( Klb) , a co‐receptor for the biological functions of fibroblast growth factor (FGF)15/19 and FGF21. DNA methyltransferases (DNMT) 1 and 3A mediate HFD‐induced methylation at the Klb promoter. Notably, HFD enhances DNMT1 protein stability via a ubiquitination‐mediated mechanism. Liver‐specific deletion of Dnmt1 or 3a increases Klb expression and ameliorates HFD‐induced hepatic steatosis. Single‐nucleus RNA sequencing analysis reveals pathways involved in fatty acid oxidation in Dnmt1 ‐deficient hepatocytes. Targeted demethylation at the Klb promoter increases Klb expression and fatty acid oxidation, resulting in decreased hepatic lipid accumulation. Up‐regulation of methyltransferases by HFD may induce hypermethylation of the Klb promoter and subsequent down‐regulation of Klb expression, resulting in the development of hepatic steatosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology, Georgia State University, Atlanta, GA, 30303, USA.
- The Northern Medical District, Chinese PLA General Hospital, Beijing, 100094, China.
- Department of Internal Medicine, University of Maryland School of Medicine, Baltimore, MD, 21201, USA.
- Department of Chemistry and the Center for Diagnosis and Therapeutics, Georgia State University, Atlanta, GA, 30303.
- GRU Cancer Center and Department of Biochemistry and Molecular Biology, Medical College of Georgia, Augusta University, Augusta, GA, 30912, USA.
- Genomic Core Lab of National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, 20855, USA.
ORCID-Profile: Hang Shi
Förderung
- NIDDK NIH HHS
- NIH HHS
- NIGMS NIH HHS
- National Institutes of Health
- National Science Foundation
Zitieren
APA
Wang, S., Zha, L., Cui, X., Yeh, Y. T., Liu, R., Jing, J., Shi, H., Chen, W., Hanover, J., Yin, J., Yu, L., Xue, B., & Shi, H. (2023). Epigenetic Regulation of Hepatic Lipid Metabolism by DNA Methylation. Advanced Science, 10(20). https://doi.org/10.1002/advs.202206068
Vancouver
Wang S, Zha L, Cui X, Yeh YT, Liu R, Jing J, et al. Epigenetic Regulation of Hepatic Lipid Metabolism by DNA Methylation. Advanced Science. 2023;10(20). doi:10.1002/advs.202206068
BibTeX
@article{Wang2023,
author = {Wang, Shirong and Zha, Lin and Cui, Xin and Yeh, Yu-Te and Liu, Ruochuan and Jing, Jia and Shi, Huidong and Chen, Weiping and Hanover, John and Yin, Jun and Yu, Liqing and Xue, Bingzhong and Shi, Hang},
title = {Epigenetic Regulation of Hepatic Lipid Metabolism by DNA Methylation},
journal = {Advanced Science},
year = {2023},
volume = {10},
number = {20},
doi = {10.1002/advs.202206068}
}
EUVIMED